ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway
Authors:
- 23 December 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 472, 70-80
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 37 references indexed in Scilit:
- Dynamic binding of RBPJ is determined by Notch signaling statusGenes & Development, 2013
- Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic valueCancer, 2013
- Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating SlugMedical Oncology, 2013
- Notch receptor–ligand binding and activation: Insights from molecular studiesSeminars in Cell & Developmental Biology, 2012
- Transcription factor ZBP-89 in cancer growth and apoptosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Highly Efficient Generation of Human Hepatocyte–Like Cells From Induced Pluripotent Stem CellsHepatology, 2009
- ZBP-89 reduces the cell death threshold in hepatocellular carcinoma cells by increasing caspase-6 and S phase cell cycle arrestCancer Letters, 2009
- Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanismBlood, 2009
- Quantitative Dissection of the Notch:CSL Interaction: Insights into the Notch-mediated Transcriptional SwitchJournal of Molecular Biology, 2007
- Overexpression of ZBP-89, a Zinc Finger DNA Binding Protein, in Gastric CancerBiochemical and Biophysical Research Communications, 1997